Latest Breaking News On - Stock incentive plan - Page 7 : comparemela.com

Foremost Lithium Reports Widest Intercept to Date; 32 53

Foremost Lithium Reports Widest Intercept to Date; 32 53
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

British columbiaUnited kingdomLac simardUnited statesLucasa zimmermanJody dahrougeMatthew carterJason barnardExchange commission regulationLithium resource technology ltdCanadian national instrumentCanadian securities exchangeMz groupHighlights includeZoro dykeLithium resource

Foremost Lithium Reports Widest Intercept to Date; 32 53 Metres of Spodumene-Bearing Pegmatite at its Zoro Lithium Project in Manitoba, Canada

Real-Time News, Market Data and Stock Quotes For Junior Mining Stocks.

Lac simardUnited statesBritish columbiaUnited kingdomLucasa zimmermanJason barnardJody dahrougeMatthew carterMz groupLithium resource technology ltdCanadian national instrumentCanadian securities exchangeExchange commission regulationHighlights includeZoro dykeLithium resource

Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer

WALTHAM, Mass., March 27, 2024 Dyne Therapeutics, Inc. , a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically.

Johng coxAmy reillyDyne therapeutics incCompensation committee of dyneChief executive officerCompensation committeeStock incentive planNasdaq listing ruleNasdaq global select marketStock incentive

Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer

Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Amy reillyJohng coxCompensation committee of dyneDyne therapeutics incNewly appointed presidentChief executiveChief executive officerCompensation committeeStock incentive planNasdaq listing ruleNasdaq global select marketStock incentive

Ocular Therapeutix Reports Inducement Grants Under Nasdaq

BEDFORD, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing.

Donald notmanPravinu dugelJoyce allaireSanjay nayakCompensation committee of ocularOcular therapeutix incExecutive chairmanChief strategy officerCompensation committeeStock incentive planNasdaq listing ruleNasdaq global marketStock incentiveOcular therapeutixNasdaq oculOcular therapeutix